Understanding the Root of REM Behavior Disorder and Other Parasomnias
Parasomnias are sleep disorders that involve abnormal behaviors, emotional experiences, perceptions, and dream activity, occurring during specific sleep stages or sleep-wake transi...
Navigating Challenges and Opportunities With AI Adoption in Neurological Practice: Lidia Maria Veras Rocha Moura, MD, PhD, MPH, FAAN
WATCH TIME: 5 minutes'What I really wanted to highlight is that we should be thinking about equity, and access. Many solutions might have the ability to increase clinician efficien...
ALS Candidate PrimeC Shows Greater Treatment Effect in High-Risk ALS
Jeremy M. Shefner, MD, PhDNewly announced analyses from the phase 2b PARADIGM trial (NCT05357950) showed that treatment with PrimeC (NeuroSense), an investigational agent made up o...
Patient Death Reported in Phase 2 DAYLIGHT Study of Pfizer’s Gene Therapy for Duchenne
A patient in the phase 2 DALIGHT trial (NCT05429372) assessing Pfizer’s investigational gene therapy fordadistrogene movaparvovec (PF-06939926) in boys with Duchenne muscular dyst...
Promising Nasal Administration Treatment for Non-Active Secondary Progressive MS: Tarun Singhal, MD, MBBS
WATCH TIME: 5 minutes'This approach with the nasal administration of the drug, we believe, actually leads to a modulation of the immune system in such a way that it makes it more r...
NeuroVoices: Kayla Scippa, on Recognizing Unmet Need in Chronic Demyelinating Polyneuropathy
Chronic demyelinating polyneuropathy (CIDP) is a neuromuscular disorder characterized by progressive weakness and impaired sensory function in the arms and legs. It is an autoimmun...
Crossover Study Highlights Pharmacokinetic Effects of DHE Powder STS101
A recently published, randomized, open-label, 5-period crossover study showed that treatment with STS101, an intranasal dihydroergotamine (DHE) powder, was safe in healthy particip...
Recent Progress in Advancing Gene Therapy for Parkinson Disease: Russell Lonser, MD
WATCH TIME: 4 minutes'I think what gene therapy provides us is a new opportunity to really target the specific problem of the disease at its core.'AB-1005 (AskBio), an investigatio...
【丁香园】刷新纪录！未充分告知手术风险，患者起诉医院获赔 900 万
本文作者：陈焰汐一起医疗事故，赔偿 902 万，是什么概念？近日，据 BMJ 报道，英国国家医疗服务体系 NHS 代下属医院对患者做出了约 100 万英镑（约合人民币 902 万元）的赔偿，刷新了 N
